These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 18309981)

  • 1. WHO urges action on drug resistant tuberculosis.
    Zarocostas J
    BMJ; 2008 Mar; 336(7642):465. PubMed ID: 18309981
    [No Abstract]   [Full Text] [Related]  

  • 2. WHO strategies for the management of drug-resistant tuberculosis.
    Rendon A; Centis R; D'Ambrosio L; Migliori GB
    Arch Bronconeumol; 2017 Mar; 53(3):95-97. PubMed ID: 27717622
    [No Abstract]   [Full Text] [Related]  

  • 3. [Managing multidrug-resistant tuberculosis].
    Antoun F; Véziris N
    Rev Mal Respir; 2011 Oct; 28(8):956-7. PubMed ID: 22099400
    [No Abstract]   [Full Text] [Related]  

  • 4. Addressing the threat of tuberculosis caused by extensively drug-resistant Mycobacterium tuberculosis.
    Wkly Epidemiol Rec; 2006 Oct; 81(41):386-90. PubMed ID: 17042081
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple drug resistance in tuberculosis.
    Reichman LB
    Chest; 1997 Sep; 112(3):855. PubMed ID: 9315829
    [No Abstract]   [Full Text] [Related]  

  • 6. Progress towards achieving global tuberculosis control: so near, yet so far.
    Zumla A; Davies PD
    Int J Tuberc Lung Dis; 2016 Mar; 20(3):285-6. PubMed ID: 27046703
    [No Abstract]   [Full Text] [Related]  

  • 7. Public health. Responding to market failures in tuberculosis control.
    Gupta R; Kim JY; Espinal MA; Caudron JM; Pecoul B; Farmer PE; Raviglione MC
    Science; 2001 Aug; 293(5532):1049-51. PubMed ID: 11463877
    [No Abstract]   [Full Text] [Related]  

  • 8. The worldwide epidemic of multidrug-resistant tuberculosis.
    The Lancet Infectious Diseases
    Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885
    [No Abstract]   [Full Text] [Related]  

  • 9. NIAID describes research priorities for fighting drug-resistant tuberculosis.
    Home Healthc Nurse; 2008 Sep; 26(8):448-9. PubMed ID: 18787482
    [No Abstract]   [Full Text] [Related]  

  • 10. Control of tuberculosis in India.
    Mohapatra PR
    Lancet; 2003 Oct; 362(9391):1243. PubMed ID: 14568763
    [No Abstract]   [Full Text] [Related]  

  • 11. Slow elimination of multidrug-resistant tuberculosis.
    Dye C; Williams BG
    Sci Transl Med; 2009 Oct; 1(3):3ra8. PubMed ID: 20368167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for global action against multidrug-resistant tuberculosis.
    Heymann SJ; Brewer TF; Wilson ME; Fineberg HV
    JAMA; 1999 Jun; 281(22):2138-40. PubMed ID: 10367825
    [No Abstract]   [Full Text] [Related]  

  • 13. Better than a pound of cure: preventing the development of multidrug-resistant tuberculosis.
    Byrne AL; Fox GJ; Marais BJ
    Future Microbiol; 2018 Apr; 13():577-588. PubMed ID: 29521120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rational 'DOTS plus' for the control of MDR-TB.
    Espinal MA; Dye C; Raviglione M; Kochi A
    Int J Tuberc Lung Dis; 1999 Jul; 3(7):561-3. PubMed ID: 10423218
    [No Abstract]   [Full Text] [Related]  

  • 15. Tuberculosis control goals unlikely to be met by 2005.
    Sharma DC
    Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013
    [No Abstract]   [Full Text] [Related]  

  • 16. Southern Africa is moving swiftly to combat the threat of XDR-TB.
    Wise J
    Bull World Health Organ; 2006 Dec; 84(12):924-5. PubMed ID: 17242824
    [No Abstract]   [Full Text] [Related]  

  • 17. WHO's 2013 global report on tuberculosis: successes, threats, and opportunities.
    Zumla A; George A; Sharma V; Herbert N; Baroness Masham of Ilton
    Lancet; 2013 Nov; 382(9907):1765-7. PubMed ID: 24269294
    [No Abstract]   [Full Text] [Related]  

  • 18. Health system factors influencing management of multidrug-resistant tuberculosis in four European Union countries - learning from country experiences.
    de Vries G; Tsolova S; Anderson LF; Gebhard AC; Heldal E; Hollo V; Cejudo LS; Schmid D; Schreuder B; Varleva T; van der Werf MJ
    BMC Public Health; 2017 Apr; 17(1):334. PubMed ID: 28424062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XDR-TB or not XDR-TB? That is the question.
    Bateman C
    S Afr Med J; 2007 May; 97(5):318, 320, 322. PubMed ID: 17599208
    [No Abstract]   [Full Text] [Related]  

  • 20. Beyond directly observed therapy for tuberculosis.
    Nolan CM
    Chest; 1997 May; 111(5):1151-3. PubMed ID: 9149558
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.